 | Up a level |
Patsenker, Eleonora; Schneider, Vreni; Ledermann, Monika; Saegesser, Hans; Dorn, Christoph; Hellerbrand, Claus; Stickel, Felix (2011). Potent antifibrotic activity of mTOR inhibitors sirolimus and everolimus but not of cyclosporine A and tacrolimus in experimental liver fibrosis. Journal of hepatology, 55(2), pp. 388-98. Amsterdam: Elsevier 10.1016/j.jhep.2010.10.044
Neef, Markus; Ledermann, Monika; Saegesser, Hans; Schneider, Vreni; Reichen, Juerg (2006). Low-dose oral rapamycin treatment reduces fibrogenesis, improves liver function, and prolongs survival in rats with established liver cirrhosis. Journal of hepatology, 45(6), pp. 786-96. Amsterdam: Elsevier 10.1016/j.jhep.2006.07.030
Neef, Markus; Ledermann, Monika; Saegesser, Hans; Schneider, Vreni; Widmer, Nicolas; Decosterd, Laurent Arthur; Rochat, Bertrand; Reichen, Juerg (2006). Oral imatinib treatment reduces early fibrogenesis but does not prevent progression in the long term. Journal of hepatology, 44(1), pp. 167-75. Amsterdam: Elsevier 10.1016/j.jhep.2005.06.015
